Semaglutide or Tirzepatide: Names, Brands, and Coverage

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, this article clarifies drug naming and coverage across the GLP-1 landscape.

"Semaglutide or tirzepatide" reads like a comparison, but most people typing it are really asking a disambiguation question: which name is the brand, which is the ingredient, and why do they appear separately? This page sorts out the relationship between brand names and active ingredients and shows why the distinction drives prescriptions, insurance, and cost.

The naming question in short

These searches usually involve either a brand name paired with its active ingredient, or two brand names for the same molecule. Untangling which is which removes most of the confusion, because the rest of the picture, coverage and cost included, follows directly from how naming is structured.

Why brand and generic names both exist

The active ingredient, also called the generic or nonproprietary name, identifies what is chemically inside the pen or tablet. The brand name is the trademark a manufacturer assigns to a finished product. One active ingredient can appear under several brand names when a manufacturer pursues different approved indications, or when generic makers enter after patents expire. As of April 2026, no true generic GLP-1 has reached the U.S. market, so branded products still dominate.

How this shapes prescriptions and insurance

Coverage, prior authorization criteria, and manufacturer savings programs all operate at the product-label level, not the molecule level. A plan that covers Ozempic for type 2 diabetes may not cover Wegovy for chronic weight management even though both contain semaglutide. Your prescriber selects the brand that matches the approved indication and your coverage.

Where compounded formulations sit

PlexusDx markets semaglutide and tirzepatide by their active-ingredient names through the Weight Management Protocols, produced as compounded formulations through a licensed compounding pharmacy pathway. The active ingredients match those in the approved brands, but the products are legally and factually different, neither brand nor generic but compounded. Published pricing appears on each product page.

Why the distinction matters to you

Knowing whether you are looking at a brand, an ingredient, or a compounded formulation changes how you read coverage rules and price quotes. It also frames the right questions for a prescriber, who ultimately matches the product to your approved indication, your history, and your plan rather than to a search term.

The genetic context beneath either name

Regardless of which molecule or brand a clinician prescribes, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO and MC4R, and TCF7L2 that shape baseline metabolism. It never predicts response to a brand or compound and is not pharmacogenomic; it maps upstream biology that applies across the board.

Reading a price quote correctly

Once the naming is clear, price quotes stop being mysterious. A figure attached to a brand reflects that specific product's label and coverage rules, while a figure attached to a compounded formulation reflects an entirely different regulatory category. Comparing them as if they were the same thing leads to confusion, because they are not interchangeable in the way a brand and its true generic would be. Knowing whether a quote refers to a brand, an active ingredient, or a compounded protocol lets you compare like with like and ask a prescriber the right coverage questions. It also clarifies why savings programs apply to some options and not others. This kind of literacy protects a reader from mismatched expectations, and it pairs naturally with the genetic context below, which applies no matter which molecule or product a clinician ultimately selects.

With the naming untangled, the rest of the picture falls into place: coverage, cost, and prescribing all follow from whether you are looking at a brand, an active ingredient, or a compounded formulation. That single distinction resolves most of the confusion behind this common search.

Frequently Asked Questions

Is a brand the same as its active ingredient?

A brand name is a trademark for a finished product, while the active ingredient is the molecule inside it. Each prescription of a brand contains its active ingredient as the working molecule. As of April 2026, there is no FDA-approved generic for these GLP-1 molecules on the U.S. market, since patent exclusivity remains active.

Why does one molecule carry multiple brand names?

Manufacturers launch the same active ingredient under different brand names when pursuing different approved indications. Coverage, prior authorization, and savings programs run at the brand level rather than the molecule level, so separate labels keep coverage logic clean. Semaglutide has three brands, and tirzepatide has two, for this reason.

Does the specific brand matter for me?

It matters for coverage, cost, and the approved indication. Your prescriber writes the brand that matches your indication and is covered by your plan. The active ingredient is the same across brands of a given molecule, but formulation, dose, and administration instructions can differ from one product to another.

Does genetic testing pick the right molecule?

No. The Precision Peptide Genetic Test does not predict response to any brand or compound. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline metabolism and appetite biology, offering upstream context that applies regardless of which brand of which molecule a clinician prescribes.

Find more naming and coverage guides in the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.